A study of Homeopathic Treatment for Attention Deficit Hyperactivity Disorder
This study is completed. It focuses on ADHD and currently lists study information in Canada.
In Toronto
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed. It focuses on ADHD and currently lists study information in Canada.
In TorontoThis study is completed. It focuses on schizophrenia and currently lists study information in the United States.
In BrooklynThis study is completed. It focuses on ADHD and currently lists study information in the United States.
Multiple locations, including Newport BeachThis study is completed. It focuses on ADHD and currently lists study information in the United States.
Multiple locations, including Newport BeachThis study is completed. It focuses on ADHD and currently lists study information in Canada.
In TorontoThis study was terminated in the United States. It is testing iV Ceftriaxone for Schizophrenia.
In New YorkThis study is completed in the United States. It is testing mirtazapine for PTSD.
In TuscaloosaThis study is completed in the United States. It focuses on PTSD.
In BostonThis study is completed. It focuses on PTSD and currently lists study information in the United States.
Multiple locations, including ScottsdaleThis study is completed. It focuses on PTSD and currently lists study information in Global.
In GlobalThis study is active but not recruiting. It focuses on PTSD and currently lists study information in the United States.
In NashvilleThis study is completed. It focuses on anxiety and currently lists study information in the United States.
Multiple locations, including New OrleansHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.